Skip to main content
PMC home page
Frontiers in Genetics logoLink to Frontiers in Genetics
. 2021 Nov 25;12:767577. doi: 10.3389/fgene.2021.767577

Impact of Liability to Periodontitis on Glycemic Control and Type II Diabetes Risk: A Mendelian Randomization Study

Parth D Shah 1, C M Schooling 1, Luisa N Borrell 1,*
PMCID: PMC8660586  PMID: 34899852

Abstract

While the association of periodontitis with Type II diabetes (T2DM) is well-established, the causal relationship remains uncertain. We examined the causal association of periodontitis with glycemic traits (HbA1c, fasting glucose, and fasting insulin) and T2DM using Mendelian randomization (MR) taking advantage of large genome-wide association studies of European and East Asian adults, i.e., the UK Biobank (n ≈ 350,000) (HbA1c), trans-ancestral MAGIC (HbA1c, fasting glucose, and insulin), and DIAMANTE (74,124 cases/824,006 controls), and AGEN for T2DM in Europeans and East Asians, respectively. Periodontitis was instrumented using single-nucleotide polymorphisms (SNPs), strongly and independently predicting liability to periodontitis in each ancestry group. SNP-specific Wald estimates were combined using inverse variance weighting. Sensitivity analyses were performed using the weighted median and MR-Egger with meta-analysis of MR estimates for Europeans and East Asians. Genetically instrumented liability to periodontitis was not associated with glycemic traits or T2DM in either ancestry or when ancestry specific estimates were meta-analyzed. Our findings do not support a causal association of liability to periodontitis with glycemic traits or T2DM. However, further research is required confirming these findings among other racial/ethnic groups, especially groups who carry a heavy burden of both periodontitis and T2DM.

Keywords: diabetes, glycemic control traits, periodontitis, epidemiology, mendelian randomization, causal analysis

1 Introduction

Type 2 diabetes (T2DM) is a leading cause of morbidity and mortality worldwide (World Health Organization, 2018; Zheng et al., 2018; Khan et al., 2020; Lin et al., 2020). About 9% of adults in the world now have diabetes mellitus, with 90% having T2DM (Zheng et al., 2018). Despite improved treatment and preventive measures, diabetes alone continues to be responsible for over a million deaths each year (World Health Organization, 2018; Khan et al., 2020). T2DM is a serious public health concern, as its burden is rising globally. Well-established risk factors include age, overweight, family history, and hypertension (American Heart Association, 2021). However, an emerging role of inflammation in glycemic control and pathogenesis of T2DM has been increasingly recognized as a means of improving prevention and control for this condition (Tsalamandris et al., 2019).

Similarly, periodontitis, one of the most common chronic inflammatory diseases of the gums and supporting structures of teeth (Papapanou et al., 2018), has long been considered a risk factor for T2DM (Preshaw and Taylor, 2011; Nazir, 2017; Liccardo et al., 2019). Periodontitis is caused by an immune response to oral bacteria (Cekici et al., 2014; Sudhakara et al., 2018) and has been associated with T2DM (Borgnakke et al., 2013; Stanko and Izakovicova, 2014; Wang T. F et al., 2014; Cao et al., 2019; Wu et al., 2020). The prevalence of periodontitis is between 20% and 50% in the general population (Nazir et al., 2020). According to the Global Burden of Disease Study, severe periodontitis was the 11th most prevalent condition in the world (GBD 2017 Disease and Injury Incidence and Prevalence Collaborators, 2017). Furthermore, some evidence suggests an association of periodontitis with poor glycemic control (Wang X et al., 2014; Cao et al., 2019). Therefore, determining whether the reported association of periodontitis with T2DM is causal is of paramount importance to population health.

A direct relationship of periodontitis with T2DM has been observed, possibly operating via insulin resistance (Mealey and Ocampo, 2007). Toxic substances, such as cysteine proteases, released by periodontal pathogenic bacteria may irritate endothelial cells and promote insulin resistance via endothelial cell inflammation and lipid deposition (Thorstensson et al., 1995; Grossi et al., 2004). In contrast, proinflammatory cytokines such as interleukin-6, C-reactive protein, and tumor necrosis factor-alpha may cause a downstream immune response, yielding antibodies reacting with endothelial cells and low-density lipoproteins, and promote insulin resistance (Preshaw and Taylor, 2011; Botero et al., 2016). However, it is unclear whether periodontitis is actually a causal target of intervention or a biomarker of the other exposures, which cause diabetes.

Previous studies have reported an association of periodontitis with diabetes (Borgnakke et al., 2013; Stanko and Izakovicova, 2014; Nazir, 2017; Liccardo et al., 2019; Wu et al., 2020). However, this well-established relationship of periodontitis with diabetes is primarily based on observational studies (Borgnakke et al., 2013; Graziani et al., 2018; Wu et al., 2020). Observational studies are subject to confounding by unknown and known factors (Fewell et al., 2007; Smith and Hemani, 2014), such as lifestyle, access to care, diet and nutrition, ill-health, and socioeconomic position, particularly as people living in poverty are often more vulnerable to T2DM (Hsu et al., 2012). Additionally, findings from clinical trials examining the effects of periodontal treatment on glycemic control in T2DM participants are mixed (Teshome and Yitayeh, 2017), with a number of trials showing no benefit of periodontal treatment in preventing or controlling T2DM (Engebretson et al., 2013; Wang T. F et al., 2014; Kara et al., 2015; Vergnes, 2015). Therefore, evidence on whether periodontitis is causally related to T2DM is lacking.

Given the lack of causal evidence for an association between periodontitis and T2DM, a potential solution is the comparison of the risk of disease in people with genetically different periodontal status, to take advantage of genetic randomization at conception. Mendelian randomization (MR), instrumental variable analysis with genetic instruments, provides an opportunity of obtaining unconfounded estimates from observational studies (Smith and Hemani, 2014; Burgess et al., 2020). In fact, a previous MR study (Yuan and Larsson, 2020) found a suggestive association of periodontitis with T2DM, but did not investigate replication or possible pathways via glycemic traits. To fill this research gap, we examined the causal relationship of genetic liability to periodontitis with glycemic traits [i.e., glycosylated hemoglobin (HbA1C), fasting glucose, and fasting insulin] and T2DM using large, available, suitable genome-wide association studies (GWAS) in both people of European and East Asian descent.

2 Materials and Methods

2.1 Overview of the Study Design

This study used MR to examine the causal relation of liability to periodontitis with T2DM and glycemic traits. MR uses genetic variants associated with a risk factor as instrumental variables (IVs), which can be tested for associations with disease outcomes (Smith and Ebrahim, 2003). This was a two-sample MR study utilizing summary genetic associations, where the single-nucleotide polymorphism (SNP)–exposure (periodontitis) and the SNP–outcomes (glycemic traits and T2DM) associations were largely taken from different studies. The main two-sample MR study was conducted in people of European descent, i.e., with instruments and exposures from different European descent populations. To repeat the analysis in people of East Asian descent, i.e., with instruments and exposures from East Asian populations, we used two-sample methods with overlapping samples.

2.2 Selection of Instrumental Variables for Periodontitis

For this study, we identified all SNPs from recent GWAS of clinically confirmed periodontitis in German, Dutch, or European American samples or from meta-analyses of these studies (Schaefer et al., 2010; Munz et al., 2017; Munz et al., 2019). Candidate SNPs were assessed for suitability against the assumptions required of a valid IV (Lawlor et al., 2008). Briefly, all IVs used must satisfy three assumptions (Lawlor et al., 2008). They must predict the exposure, only affect the outcome via affecting this exposure, and should not be associated with confounders of the exposure–outcome relationship.

This study was conducted utilizing the same SNPs used by previous studies examining the causal associations of periodontitis with hypertension (Czesnikiewicz-Guzik et al., 2019) and with cardiovascular diseases (Bell et al., 2020). Only independent (r 2 < 0.01) SNPs associated with liability to periodontitis at genome-wide significance (p < 5 × 10–8) were included. In cases where multiple SNPs were identified at the same locus, only the “lead” SNP (i.e., with the smallest p-value) was included. A total of five SNPs in GLT6D1 (rs1537415), LOC107984137 (rs729876), MTND1P5 (rs16870060), DEFA1A3 (rs2738058), and SIGLEC5 (rs4284742) loci, previously associated with periodontitis (with p < 5 × 10–8) in GWAS, were identified for inclusion (Table 1) as IVs in our MR study (Munz et al., 2017; Munz et al., 2019).

Table 1.

Characteristics of the SNPs predicting liability to periodontitis selected as instrumental variables for the Mendelian randomization analysis in Europeans and East Asians.

Population SNP locus Gene Effect allele Non effect allele Effect allele frequency Beta Standard error Odds ratio 95% confidence interval
European rs1537415 9q34.3 GLT6D1 C G 0.41 0.4637 0.0797 1.59 (1.36, 1.86)
rs4284742 19q13.41 SIGLEC5 G A 0.76 0.2927 0.0521 1.34 (1.21, 1.48)
rs2738058 8p23.1 DEFA1A3 T C 0.43 0.2469 0.0415 1.28 (1.18, 1.39)
rs16870060 8q22.3 MTND1P5 G T 0.91 0.3075 0.0513 1.36 (1.23, 1.50)
rs729876 16p13.12 LOC107984137 T C 0.82 0.2151 0.0384 1.24 (1.15, 1.34)
East Asians rs10737249 1 COLGALT2 C T 0.91 0.2329 0.0457
rs192911809 12 SRRM4 A G 0.01 1.2330 0.2525
rs117963472 18 RP11-161I6.2 G A 0.02 0.4169 0.0903
rs118016840 21 DSCR8 G C 0.01 0.6304 0.1247
rs9812091 3 CLSTN2 G A 0.45 0.1218 0.0252
rs7756559 6 RP1-153P14.7 T C 0.01 0.5933 0.1281
rs35067614 7 NECAP1P1 G T 0.18 -0.1622 0.0333
Open in a new tab

The F-statistics was obtained directly from a recent study (Bell et al., 2020) using the same SNPs, or calculated using an established approximation (Bowden et al., 2016). To assess potential pleiotropy, we obtained known genome-wide associations of each SNP used in this study from a curated phenotype to genotype cross-reference, MR-PheWAS (Millard et al., 2015). Replication was conducted using Biobank Japan (Nagai et al., 2017) to obtain East Asian-specific genetic predictors of liability to periodontitis (r > 0.01 using the East Asian reference panel and p < 5 × 10−6) in 3,219 cases and 209,234 controls. Power calculations were conducted using the approximation that sample size required for an MR study is the sample size for exposure on outcome divided by the r 2 for genetic instruments on exposure (Freeman et al., 2013).

2.3 Outcomes

Genetic associations with HbA1C were obtained from the UK Biobank summary statistics of (n = 361,194) people of White British ancestry, adjusted for sex, age, age2, sex*age, sex*age2, and 20 principal components for ancestry http://www.nealelab.is/uk-biobank/(Sudlow et al., 2015). Quality-controlled genetic associations with fasting glucose (mmol/L) (n = 46,613) and fasting insulin (pmol/L) (n = 43,750) in people of European descent without diabetes were obtained from MAGIC (Chen et al., 2021). Genetic associations were adjusted for body mass index (BMI), study-specific covariates, and principal components unless using a linear mixed model (Chen et al., 2021). DIAMANTE, the largest diabetes GWAS (74,124 T2DM cases and 824,006 controls), was used to obtain genetic associations with T2DM (Mahajan et al., 2018). Genetic associations with T2DM in Europeans were also obtained from FinnGen consortium (11,006 T2DM diabetes cases and 82,655 controls) (https://www.finngen.fi/fi). Similar genetic associations were also obtained from AGEN for East Asians. Specifically, trans-ancestral MAGIC GWAS (Chen et al., 2021) for East Asians was utilized to obtain genetic associations with HbA1C, fasting glucose, and fasting insulin in up to 33,307 people, and a GWAS of East Asians (Spracklen et al., 2020) including Biobank Japan (Imamura et al., 2016) to obtain genetic associations with T2DM (77,418 cases and 356,122 controls).

2.4 Statistical Analysis

SNPs were aligned on the same effect allele for exposure and outcome, also using effect allele frequency for palindromic SNPs. rs1537415 is palindromic with allele frequency 58%, so it could not be unequivocally aligned. Therefore, analyses were conducted with and without the palindromic SNP. In the primary analysis, SNP-specific Wald estimates (the estimate for SNP on outcome divided by the estimate for SNP on periodontitis) were combined using inverse variance weighting (IVW) with multiplicative random effects, which assumes balanced pleiotropy. Population-specific MR estimates for the same associations were combined using meta-analysis, with fixed effects when heterogeneity was low and random effects when heterogeneity was high (>30%).

2.5 Sensitivity Analysis

We used leave-out one plots to assess heterogeneity. We used weighted median (WM) and MR-Egger as sensitivity analysis (Burgess and Thompson, 2017). The WM may provide correct estimates even when the instruments, i.e., SNPs, are invalid for up to 50% of the weight. To test for horizontal pleiotropy, we used the intercept and 95% confidence interval (CI) of the MR-Egger regression line (Bowden et al., 2015). We assessed heterogeneity between the causal estimates of individual SNPs using Cochran’s Q-statistic for the IVW and MR-Egger methods. MR-Egger can be imprecise if the number of genetic instruments is low.

Statistical analyses were performed using ld_clump to select genetic instruments, and the MR package (Yavorska and Burgess, 2017) and metafor to combine estimates from different outcome studies in R (R Core Team, 2020). Two-sided p-values are reported throughout, with correction for multiple testing using a p-value of 0.05/2 = 0.025, given one disease outcome, diabetes, and one set of glycemic traits. This level of correction provides a balance between rigorous results and avoids false negatives. We used publicly available de-identified summary data without direct contact with study participants. Therefore, no ethical approval was required.

3 Results

3.1 Genetic Association With Periodontitis

Five uncorrelated SNPs, rs1537415, rs4284742, rs2738058, rs16870060, and rs729876, strongly associated with periodontitis (effect sizes of log transformed values) obtained from a GWAS (Munz et al., 2017; Munz et al., 2019) were used as instruments for making causal inferences about the role of periodontitis in glycemic traits and T2DM in Europeans (Table 1). Seven uncorrelated SNPs were obtained for liability to periodontitis in East Asians (Table 1); all had F-statistic >10 with average 23.6. Estimated F-statistics were >20 for Europeans, and therefore, hardly any weak-instrument bias would be expected (Bell et al., 2020). Consistent with a previous study (Bell et al., 2020), the proportion of variance explained in liability to periodontitis by each SNP was low. We also saw the highest proportion for rs1537415. This SNP explained 1.9% of the variance in periodontitis seen in a study (Bell et al., 2020). The other SNPs each explained approximately 0.3% of the phenotypic variance observed in their respective cohorts (Bell et al., 2020). At 80% power and 5% alpha, this study could approximately detect an odds ratio of 1.07 for diabetes and of 0.02 of an effect size for HbA1c.

Of the five SNPs used to predict periodontitis in people of European descent, only rs4284742, rs2738058, and rs16870060 had known genome-wide associations with other phenotypes (Supplementary Table S1), most notably with immune cell counts for rs2738058, and with dental problems for rs4284742. Of the seven SNPs used to predict periodontitis in people of East Asian descent, only rs35067614 and rs10737249 had known genome-wide significant associations with other phenotypes (Supplementary Table S1), most notably with sitting height for rs10737249. As such, these associations most likely reflect vertical, and not horizontal, pleiotropy, and they were not excluded to preserve the phenotype. Correspondingly, the leave-out-one plots did not indicate heterogeneity (Figure 1).

FIGURE 1.

FIGURE 1

Open in a new tab

Leave-out-one plots for associations of liability to periodontitis with HbA1c, fasting glucose, fasting insulin, and diabetes in people of European and East Asian descent.

3.2 Association of Liability to Periodontitis With Glycemic Traits

As shown in Table 2, all the analyses utilizing five SNPs or four SNPs in Europeans and seven SNPs in East Asians, respectively, genetically predicted that liability to periodontitis was unrelated to HbA1C, fasting glucose, and fasting insulin using IVW or WM. The MR-Egger intercepts were not different from the null value.

TABLE 2.

Mendelian randomization estimates for liability to periodontitis on HbA1C, fasting glucose and fasting insulin, and T2DM using all five or four SNPs to predict periodontitis obtained from Europeans for the MR estimates in Europeans and seven SNPs to predict periodontitis in East Asians for the MR estimates in East Asians.

Outcome Data source Method #SNPs Beta 95% confidence interval p-value Cochran’s Q-statistic (p-value) MR-Egger
Intercept p-value I 2
HbA1C (effect size) United Kingdom Biobank IVW 5 −0.001 −0.008 to 0.006 0.74 1.38 (0.85) 0%
4 0.001 −0.010 to 0.011 0.91 1.17 (0.76) 0%
WM 5 −0.003 −0.011 to 0.006 0.56
4 −0.002 −0.014 to 0.011 0.81
MRE 5 −0.007 −0.032 to 0.018 0.58 1.14 (0.77) 0.63 71.0%
4 −0.006 −0.089 to 0.077 0.89 1.14 (0.56) 0.88 14.9%
MAGIC IVW 7 −0.007 −0.024 to 0.010 0.45 7.65 (0.26) 21.6%
East Asians WM 7 −0.014 −0.033 to 0.006 0.18
MRE 7 −0.018 −0.047 to 0.012 0.24 6.55 (0.35) 0.36 0%
Fasting glucose (mmol/L) MAGIC IVW 5 −0.001 −0.007 to 0.005 0.74 1.81 (0.77) 0%
Europeans 4 −0.003 −0.011 to 0.006 0.55 1.55 (0.67) 0%
WM 5 0.0004 −0.007 to 0.007 0.91
4 −0.002 −0.013 to 0.008 0.71
MRE 5 −0.001 −0.021to 0.020 0.96 1.81 (0.62) 0.97 71.4%
4 −0.043 -0.112 to 0.025 0.22 0.19 (0.91) 0.24 16.7%
MAGIC IVW 7 0.023 −0.005 to 0.051 0.11 9.39 (0.15) 36.1
East Asians WM 7 0.018 −0.013 to 0.050 0.26
MRE 7 0.037 −0.013 to 0.087 0.15 8.57 (0.13) 0.49 0%
Fasting insulin (pmol/L) MAGIC IVW 5 −0.002 −0.010 to 0.006 0.62 5.3 (0.26) 23.8%
Europeans 4 −0.008 −0.018 to 0.002 0.12 2.8 (0.43) 0%
WM 5 0.002 −0.006 to 0.010 0.66
4 −0.006 −0.019 to 0.007 0.34
MRE 5 0.013 −0.012 to 0.037 0.31 3.5 (0.32) 0.22 72.5%
4 −0.023 −0.113 to 0.067 0.62 2.6 (0.27) 0.74 15.6%
MAGIC IVW 7 0.010 −0.027 to 0.047 0.58 11.7 (0.07) 48.7%
East Asians WM 7 0.004 −0.035 to 0.042 0.85
MRE 7 0.045 −0.013 to 0.102 0.13 8.21 (0.35) 0.14 0%
Odds Ratio
Diabetes DIAMANTE IVW 5 1.02 1.00 to 1.04 0.08 3.40 (0.49) 0%
Europeans 4 1.03 1.00 to 1.06 0.053 2.36 (0.50) 0%
WM 5 1.02 0.99 to 1.04 0.18
4 1.03 1.00 to 1.07 0.06
MRE 5 1.00 0.93 to 1.07 0.99 3.12 (0.37) 0.60 71.8%
4 1.17 0.93 to 1.47 0.18 1.15 (0.56) 0.27 22.5%
Finngen a IVW 4 0.97 0.92 to 1.03 0.34 2.10 (0.55) 0%
Europeans 3 0.96 0.89 to 1.03 0.27 1.72 (0.42) 0%
WM 4 0.98 0.92 to 1.05 0.57
3 0.96 0.87 to 1.06 0.39
MRE 4 1.07 0.88 to 1.32 0.49 1.16 (0.56) 0.33 62.3%
3 1.60 0.71 to 3.64 0.26 0.18 (0,67) 0.22 0%
AGEN IVW 7 1.00 0.96 to 1.03 0.91 5.38 (0.50) 0%
East Asians WM 7 0.98 0.94, to 1.03 0.45
MRE 7 0.97 0.92 to 1.03 0.32 4.01 (0.55) 0.24 0%
Meta-analysis Of IVW estimates 12 1.01 0.99 to 1.03 0.28
11 1.01 0.99 to 1.03 0.30
Open in a new tab
a

Rs729876 not available.

3.3 Association of Liability to Periodontitis With T2DM

Using all five SNPs as instruments for liability to periodontitis, there was no association of genetically predicted periodontitis with the risk of T2DM in DIAMANTE, or East Asians as presented in Table 2. This finding was also observed in FinnGenn regardless of whether four or three SNPS were used. Similar estimates were identified from the weighted median and MR-Egger sensitivity analyses. The MR-Egger intercept did not detect any directional pleiotropy for any outcome.

4 Discussion

We examined the causal association of periodontitis with glycemic traits (HbA1C, fasting glucose, and fasting insulin) and T2DM using an MR study. While the observational epidemiological findings suggest poor glycemic control (HbA1C) in patients with periodontitis (Taylor et al., 1996; Borgnakke et al., 2013), we found no reliable evidence for a causal association of liability to periodontitis with these glycemic traits or T2DM.

We identified and included five independent SNPs, associated with clinically defined periodontitis at a genome-wide significance. These SNPs have previously been used in another MR study (Bell et al., 2020). These five SNPs were all identified in cohort studies of aggressive periodontitis only, or of a mix of both aggressive and chronic periodontitis (Munz et al., 2017; Munz et al., 2019). Because chronic periodontitis is the predominant form of the disease, GWAS of solely aggressive periodontitis may not comprehensively capture the relevant phenotype or comprehensively identified genome-wide significant variants associated with the disease (Divaris et al., 2013; Teumer et al., 2013; Feng et al., 2014; Shaffer et al., 2014; Hong et al., 2015; Shimizu et al., 2015).

Confounding may be an explanation as to why these findings differ from observational studies (Fewell et al., 2007). Periodontitis and glycemic traits are both multifactorial in nature, representing individuals’ many years of exposure to risk factors. Observed associations could be confounded by other factors. For instance, smoking is an important risk factor for both periodontitis and glycemic traits (Genco and Borgnakke, 2013; U.S. Food & Drug Administration, 2020). Other possible confounders include age, obesity, and socioeconomic position (Genco and Borgnakke, 2013; U.S. Food & Drug Administration, 2020; American Heart Association, 2021). Obesity, a known contributor to the risk of increased HbA1C, fasting glucose, and fasting insulin (American Heart Association, 2021), has also been found to affect the development of periodontitis (Genco and Borgnakke, 2013). However, our study did not find a causal relationship of periodontitis with glycemic traits. Therefore, there is no evidence for prioritizing treatment of periodontitis for the control of glycemic traits.

A previous MR study reported an association of periodontitis with blood pressure, even though the association accounted for only a very small portion of blood pressure variation (Czesnikiewicz-Guzik et al., 2019). Hypertension is a well-established risk factor for T2DM (American Heart Association, 2021). It is likely that the contribution of periodontitis to hypertension might be small, and as a result, we did not observe evidence of a causal association of periodontitis with T2DM. This finding is inconsistent with the possible association suggested by a previous MR study (Yuan and Larsson, 2020) examining a series of risk factors for type 2 diabetes. However, the previous study did not investigate replication or possible pathways via glycemic traits.

Our study had a number of limitations worth discussing. The variance explained by the five SNPs used was relatively low, because the selected variants are associated with the aggressive form of periodontitis. However, the F-statistics were larger than 10. Furthermore, we selected the lead SNP from each locus, not on the basis of a linkage disequilibrium threshold as it is usually done. It is therefore plausible that more instruments might have given more conclusive findings. However, we chose variants drawn from three separate GWAS with unavailable full summary statistics. Our findings should be considered in the context of the underlying assumptions and limitations of MR. First, estimates derived from MR analyses generally represent the effect of cumulative exposure to a risk factor, and thus, may not correspond exactly to the expected outcome of a particular exposure, with regards to duration, timing, and mechanism. The genetic associations with fasting glucose and insulin were adjusted for BMI (Chen et al., 2021), which could bias as a heritable covariate (Aschard et al., 2015), possibly towards the null. However, the associations for liability to periodontitis with fasting glucose and fasting insulin were similar to those for HbA1c. Also, MR studies are open to survival bias. We could not totally exclude the possibility that the null results might be explained in part by prior deaths from sequalae of T2DM and from other conditions that preclude people living long enough to have periodontitis.

This study considers mostly people of European and East Asian descent because of the availability of suitable GWAS although separate samples for exposure and outcome were only available for people of European descent. However, bias from using overlapping samples may not be as much of a concern as has been thought (Minelli et al., 2021). Periodontitis may manifest differently in different populations, but there is no evidence of population-specific mechanisms. Moreover, using publicly available data precludes subgroup analysis by age, sex, and baseline periodontal status. Finally, we were not able to conduct a bi-directional MR study giving associations of glycemic traits or T2DM with periodontitis because the relevant GWAS are too small for meaningful analysis or are not publicly available. Previous evidence concerning a bi-directional association of diabetes with periodontitis is limited (Taylor and Borgnakke, 2008; Taylor et al., 1996).

Despite these limitations, our study had several strengths. We conducted the analyses using five liability to periodontitis SNPs as well as four such SNPs, and use multiple sensitivity analyses to confirm our results. We did not identify a causal association of periodontitis with glycemic traits or T2DM using IVW, WM, or MR-Egger methods. The consistency of these findings with both analyses using five SNPs and four SNPs, and the large sample sizes used for both outcomes suggest robustness. We also included analysis for East Asians and replicated based on genetic instruments from a similar population.

The GWAS of liability of periodontitis to date failed to identify consistent SNPs (Divaris et al., 2013; Teumer et al., 2013; Feng et al., 2014; Shaffer et al., 2014; Hong et al., 2015; Shimizu et al., 2015). The reason for divergent SNPs identified in periodontitis GWAS could be due to inconsistent definitions of periodontitis that were used in different studies (Sun et al., 2020). To confirm the causal effect of periodontitis on risk of glycemic traits and T2DM, stronger instruments for periodontitis derived from large-scale GWAS with a consistent definition of periodontitis (Caton et al., 2018) are warranted. It is also of interest to perform similar studies in a wider range of racial/ethnic populations.

In conclusion, we found that liability to periodontitis was associated neither with glycemic traits nor with T2DM. While these findings are intriguing, MR analysis provides strong evidence of a non-causal association of periodontitis with glycemic traits and T2DM risk. However, more research is required to confirm these findings among other racial/ethnic groups, especially groups who seem to carry a heavy burden of both periodontitis and T2DM.

Data Availability Statement

Publicly available datasets were analyzed in this study. These data can be found here: United Kingdom Biobank Summary Statistics: http://www.nealelab.is/uk-biobank/; MAGIC https://magicinvestigators.org; DIAMANTE https://magicinvestigators.org; AGEN https://hugeamp.org/downloads.html#T2D; FinnGenn https://www.finngen.fi/fi; and Biobank Japan http://jenger.riken.jp/result.

Author Contributions

PS, CS, and LB designed the study; CS analyzed the data; PS, CS, and LB drafted and revised the manuscript; all authors approved the final version of the manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fgene.2021.767577/full#supplementary-material

Click here for additional data file. (11.9KB, XLSX)

References

  1. American Heart Association. (2021). Diabetes Risk Factors. Available at: https://www.heart.org/en/health-topics/diabetes/understand-your-risk-for-diabetes [Accessed March 6, 2021].
  2. Aschard H., Vilhjálmsson B. J., Joshi A. D., Price A. L., Kraft P. (2015). Adjusting for Heritable Covariates Can Bias Effect Estimates in Genome-wide Association Studies. Am. J. Hum. Genet. 96, 329–339. 10.1016/j.ajhg.2014.12.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bell S., Gibson J. T., Harshfield E. L., Markus H. S. (2020). Is Periodontitis a Risk Factor for Ischaemic Stroke, Coronary Artery Disease and Subclinical Atherosclerosis? A Mendelian Randomization Study. Atherosclerosis 313, 111–117. 10.1016/j.atherosclerosis.2020.09.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Borgnakke W. S., Ylöstalo P. V., Taylor G. W., Genco R. J. (2013). Effect of Periodontal Disease on Diabetes: Systematic Review of Epidemiologic Observational Evidence. J. Clin. Periodontol. 40, S135–S152. 10.1111/jcpe.12080 [DOI] [PubMed] [Google Scholar]
  5. Botero J. E., Rodríguez C., Agudelo-Suarez A. A. (2016). Periodontal Treatment and Glycaemic Control in Patients with Diabetes and Periodontitis: an Umbrella Review. Aust. Dent J. 61, 134–148. 10.1111/adj.12413 [DOI] [PubMed] [Google Scholar]
  6. Bowden J., Smith G. D., Burgess S. (2015). Mendelian Randomization with Invalid Instruments: Effect Estimation and Bias Detection through Egger Regression. Int. J. Epidemiol. Apr 44 (2), 512–525. 10.1093/ije/dyv080 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bowden J., Del Greco M. F., Minelli C., Smith G. D., Sheehan N. A., Thompson J. R. (2016). Assessing the Suitability of Summary Data for Two-Sample Mendelian Randomization Analyses Using MR-Egger Regression: the Role of the I2 Statistic. Int. J. Epidemiol. 45 (6), 1961–1974. 10.1093/ije/dyw220 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Burgess S., Smith G. D., Davies N. M., Dudbridge F., Gill D., Glymour M. M., et al. (2020). Guidelines for Performing Mendelian Randomization Investigations. Wellcome Open Res. 4, 186. 10.12688/wellcomeopenres.15555.2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Burgess S., Thompson S. G. (2017). Interpreting Findings from Mendelian Randomization Using the MR-Egger Method. Eur. J. Epidemiol. 32, 377–389. 10.1007/s10654-017-0255-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cao R., Li Q., Wu Q., Yao M., Chen Y., Zhou H. (2019). Effect of Non-surgical Periodontal Therapy on Glycemic Control of Type 2 Diabetes Mellitus: a Systematic Review and Bayesian Network Meta-Analysis. BMC Oral Health 19, 176. 10.1186/s12903-019-0829-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Caton J. G., Armitage G., Berglundh T., Chapple I. L. C., Jepsen S., Kornman K. S., et al. (2018). A New Classification Scheme for Periodontal and Peri-Implant Diseases and Conditions - Introduction and Key Changes from the 1999 Classification. J. Clin. Periodontol. 45 (Suppl. 20), S1–S8. 10.1111/jcpe.12935 [DOI] [PubMed] [Google Scholar]
  12. Cekici A., Kantarci A., Hasturk H., Van Dyke T. E. (2014). Inflammatory and Immune Pathways in the Pathogenesis of Periodontal Disease. Periodontol. 2000 64, 57–80. 10.1111/prd.12002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chen J., Spracklen C. N., Marenne G., Varshney A., Corbin L. J., Luan J., et al. (2021). The Trans-ancestral Genomic Architecture of Glycemic Traits. Nat. Genet. 53, 840–860. 10.1038/s41588-021-00852-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Czesnikiewicz-Guzik M., Osmenda G., Siedlinski M., Nosalski R., Pelka P., Nowakowski D., et al. (2019). Causal Association between Periodontitis and Hypertension: Evidence from Mendelian Randomization and a Randomized Controlled Trial of Non-surgical Periodontal Therapy. Eur. Heart J. 40, 3459–3470. 10.1093/eurheartj/ehz646 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Divaris K., Monda K. L., North K. E., Olshan A. F., Reynolds L. M., Hsueh W. C., et al. (2013). Exploring the Genetic Basis of Chronic Periodontitis: a Genome-wide Association Study. Hum. Mol. Genet. 22, 2312–2324. 10.1093/hmg/ddt065 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Engebretson S. P., Hyman L. G., Michalowicz B. S., Schoenfeld E. R., Gelato M. C., Hou W., et al. (2013). The Effect of Nonsurgical Periodontal Therapy on Hemoglobin A1c Levels in Persons with Type 2 Diabetes and Chronic Periodontitis: a Randomized Clinical Trial. JAMA 310, 2523–2532. 10.1001/jama.2013.282431 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Feng P., Wang X., Casado P. L., Küchler E. C., Deeley K., Noel J., et al. (2014). Genome Wide Association Scan for Chronic Periodontitis Implicates Novel Locus. BMC Oral Health 1, 84. 10.1186/1472-6831-14-84 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fewell Z., Smith G. D., Sterne J. A. (2007). The Impact of Residual and Unmeasured Confounding in Epidemiological Studies; a Simulation Study. Am. J. Epidemiol. 166, 646–655. 10.1093/aje/kwm165 [DOI] [PubMed] [Google Scholar]
  19. Freeman G., Cowling B. J., Schooling C. M. (2013). Power and Sample Size Calculations for Mendelian Randomization Studies Using One Genetic Instrument. Int. J. Epidemiol. 42, 1157–1163. 10.1093/ije/dyt110 [DOI] [PubMed] [Google Scholar]
  20. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2017). Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 328 Diseases and Injuries for 195 Countries, 1990–2016: a Systematic Analysis for the Global Burden of Disease Study 2016. Lancet 390, 1211–1259. 10.1016/S0140-6736(17)32154-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Genco R. J., Borgnakke W. S. (20132000). Risk Factors for Periodontal Disease. Periodontol 62, 59–94. 10.1111/j.1600-0757.2012.00457.x [DOI] [PubMed] [Google Scholar]
  22. Graziani F., Gennai S., Solini A., Petrini M. A. (2018). A Systematic Review and Meta-Analysis of Epidemiologic Observational Evidence on the Effect of Periodontitis on Diabetes an Update of the EFP-AAP Review. J. Clin. Periodontol. 45, 167–187. 10.1111/jcpe.12837 [DOI] [PubMed] [Google Scholar]
  23. Grossi S. G., Mealey B. L., Rose L. F. (2004). Effect of Periodontal Infection on Systemic Health and Well-Being. Periodontics: Medicine, Surgery and Implants. St. Louis, MO: Elsevier Mosby. [Google Scholar]
  24. Hong K. W., Shin M. S., Ahn Y. B., Lee H. J., Kim H. D. (2015). Genomewide Association Study on Chronic Periodontitis in Korean Population: Results from the Yangpyeong Health Cohort. J. Clin. Periodontol. 42, 703–710. 10.1111/jcpe.12437 [DOI] [PubMed] [Google Scholar]
  25. Hsu C. C., Lee C. H., Wahlqvist M. L., Huang H. L., Chang H. Y., Chen L., et al. (2012). Poverty Increases Type 2 Diabetes Incidence and Inequality of Care Despite Universal Health Coverage. Diabetes Care 35, 2286–2292. 10.2337/dc11-2052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Imamura M., Takahashi A., Yamauchi T., Hara K., Yasuda K., Grarup N., et al. (2016). Genome-wide Association Studies in the Japanese Population Identify Seven Novel Loci for Type 2 Diabetes. Nat. Commun. 7, 10531. 10.1038/ncomms10531 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kara G., Cifcibasi E., Karsidag K., Cintan S. (2015). Short Term Effects of Periodontal Therapy on Inflammatory Markers in Patients with Type-2 Diabetes. Saudi Med. J. 36, 469–476. 10.15537/smj.2015.4.10380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Khan M. A. B., Hashim M. J., King J. K., Govender R. D., Mustafa H., Al Kaabi J. (2020). Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J. Epidemiol. Glob. Health 10, 107–111. 10.2991/jegh.k.191028.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lawlor D. A., Harbord R. M., Sterne J. A., Timpson N., Smith G. D. (2008). Mendelian Randomization: Using Genes as Instruments for Making Causal Inferences in Epidemiology. Stat. Med. 27, 1133–1163. 10.1002/sim.3034 [DOI] [PubMed] [Google Scholar]
  30. Liccardo D., Cannavo A., Spagnuolo G., Ferrara N., Cittadini A., Rengo C., et al. (2019). Periodontal Disease: A Risk Factor for Diabetes and Cardiovascular Disease. Int. J. Mol. Sci. 20, 1414. 10.3390/ijms20061414 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lin X., Xu Y., Pan X., Xu J., Ding Y., Sun X., et al. (2020). Global, Regional, and National burden and Trend of Diabetes in 195 Countries and Territories: an Analysis from 1990 to 2025. Sci. Rep. 10, 14790. 10.1038/s41598-020-71908-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mahajan A., Taliun D., Thurner M., Robertson N. R., Torres J. M., Rayner N. W., et al. (2018). Fine-mapping Type 2 Diabetes Loci to Single-Variant Resolution Using High-Density Imputation and Islet-specific Epigenome Maps. Nat. Genet. 50, 1505–1513. 10.1038/s41588-018-0241-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mealey B. L., Ocampo G. L. (2007). Diabetes Mellitus and Periodontal Disease. Periodontol. 2000 44, 127–153. 10.1111/j.1600-0757.2006.00193.x [DOI] [PubMed] [Google Scholar]
  34. Millard L. A., Davies N. M., Timpson N. J., Tilling K., Flach P. A., Smith G. D. (2015). MR-PheWAS: Hypothesis Prioritization Among Potential Causal Effects of Body Mass Index on Many Outcomes, Using Mendelian Randomization. Sci. Rep. 5, 16645. 10.1038/srep16645 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Minelli C., Del Greco M. F., van der Plaat D. A., Bowden J., Sheehan N. A., Thompson J. (2021). The Use of Two-Sample Methods for Mendelian Randomization Analyses on Single Large Datasets. Int. J Epidemiol. Apr 26:dyab084. Epub ahead of print. 10.1093/ije/dyab084 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Munz M., Richter G. M., Loos B. G., Jepsen S., Divaris K., Offenbacher S., et al. (2019). Meta-analysis of Genome-wide Association Studies of Aggressive and Chronic Periodontitis Identifies Two Novel Risk Loci. Eur. J. Hum. Genet. 27, 102–113. 10.1038/s41431-018-0265-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Munz M., Willenborg C., Richter G. M., Jockel-Schneider Y., Graetz C., Staufenbiel I., et al. (2017). A Genome-wide Association Study Identifies Nucleotide Variants at SIGLEC5 and DEFA1A3 as Risk Loci for Periodontitis. Hum. Mol. Genet. 26, 2577–2588. 10.1093/hmg/ddx151 [DOI] [PubMed] [Google Scholar]
  38. Nagai A., Hirata M., Kamatani Y., Muto K., Matsuda K., Kiyohara Y., et al. (2017). Overview of the BioBank Japan Project: Study Design and Profile. J. Epidemiol. 27, S2–S8. 10.1016/j.je.2016.12.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Nazir M., Al-Ansari A., Al-Khalifa K., Alhareky M., Gaffar B., Almas K. (2020). Global Prevalence of Periodontal Disease and Lack of its Surveillance. ScientificWorldJournal 2020, 2146160. 10.1155/2020/2146160 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Nazir M. A. (2017). Prevalence of Periodontal Disease, its Association with Systemic Diseases and Prevention. Int. J. Health Sci. (Qassim). 11, 72–80. [PMC free article] [PubMed] [Google Scholar]
  41. Papapanou P. N., Sanz M., Buduneli N., Dietrich T., Feres M., Fine D. H., et al. (2018). Periodontitis: Consensus Report of Workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Periodontol. 89, S173–S182. 10.1002/jper.17-0721 [DOI] [PubMed] [Google Scholar]
  42. Preshaw P. M., Taylor J. J. (2011). How Has Research into Cytokine Interactions and Their Role in Driving Immune Responses Impacted Our Understanding of Periodontitis. J. Clin. Periodontol. 38, 60–84. 10.1111/j.1600-051x.2010.01671.x [DOI] [PubMed] [Google Scholar]
  43. R Core Team (2020). R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. Available at: https://www.R-project.org/ . [Google Scholar]
  44. Schaefer A. S., Richter G. M., Nothnagel M., Manke T., Dommisch H., Jacobs G., et al. (2010). A Genome-wide Association Study Identifies GLT6D1 as a Susceptibility Locus for Periodontitis. Hum. Mol. Genet. 19, 553–562. 10.1093/hmg/ddp508 [DOI] [PubMed] [Google Scholar]
  45. Shaffer J. R., Polk D. E., Wang X., Feingold E., Weeks D. E., Lee M. K., et al. (2014). Genome-wide Association Study of Periodontal Health Measured by Probing Depth in Adults Ages 18-49 Years. G3 Genes - Genomes - Genet. 4, 307–314. 10.1534/g3.113.008755 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Shimizu S., Momozawa Y., Takahashi A., Nagasawa T., Ashikawa K., Terada Y., et al. (2015). A Genome-wide Association Study of Periodontitis in a Japanese Population. J. Dent. Res. 94, 555–561. 10.1177/0022034515570315 [DOI] [PubMed] [Google Scholar]
  47. Smith G. D., Ebrahim S. (2003). ‘Mendelian Randomization’: Can Genetic Epidemiology Contribute to Understanding Environmental Determinants of Disease? Int. J. Epidemiol. 32, 1–22. 10.1093/ije/dyg070 [DOI] [PubMed] [Google Scholar]
  48. Smith G. D., Hemani G. (2014). Mendelian Randomization: Genetic Anchors for Causal Inference in Epidemiological Studies. Hum. Mol. Genetsep 23, R89–R98. 10.1093/hmg/ddu328 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Spracklen C. N., Horikoshi M., Kim Y. J., Lin K., Bragg F., Moon S., et al. (2020). Identification of Type 2 Diabetes Loci in 433,540 East Asian Individuals. Nature 582, 240–245. 10.1038/s41586-020-2263-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Stanko P., Izakovicova H. L. (2014). Bidirectional Association between Diabetes Mellitus and Inflammatory Periodontal Disease. A. Review. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 158, 35–38. 10.5507/bp.2014.005 [DOI] [PubMed] [Google Scholar]
  51. Sudhakara P., Gupta A., Bhardwaj A., Wilson A. (2018). Oral Dysbiotic Communities and Their Implications in Systemic Diseases. Dent J. (Basel). 6, 10. 10.3390/dj6020010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Sudlow C., Gallacher J., Allen N., Beral V., Burton P., Danesh J., et al. (2015). UK Biobank: an Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age. Plos Med. 12, e1001779. 10.1371/journal.pmed.1001779 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Sun Y. Q., Richmond R. C., Chen Y., Mai X. M. (2020). Mixed Evidence for the Relationship between Periodontitis and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study. PLoS One 15, e0228206. 10.1371/journal.pone.0228206 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Taylor G. W., Borgnakke W. S. (2008). Periodontal Disease: Associations with Diabetes, Glycemic Control and Complications. Oral Dis. 14, 191–203. 10.1111/j.1601-0825.2008.01442.x [DOI] [PubMed] [Google Scholar]
  55. Taylor G. W., Burt B. A., Becker M. P., Genco R. J., Shlossman M., Knowler W. C., et al. (1996). Severe Periodontitis and Risk for Poor Glycemic Control in Patients with Non-insulin-dependent Diabetes Mellitus. J. Periodontol. 67, 1085–1093. 10.1902/jop.1996.67.10s.1085 [DOI] [PubMed] [Google Scholar]
  56. Teshome A., Yitayeh A. (2017). The Effect of Periodontal Therapy on Glycemic Control and Fasting Plasma Glucose Level in Type 2 Diabetic Patients: Systematic Review and Meta-Analysis. BMC Oral Health 17, 31. 10.1186/s12903-016-0249-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Teumer A., Holtfreter B., Völker U., Petersmann A., Nauck M., Biffar R., et al. (2013). Genome-wide Association Study of Chronic Periodontitis in a General German Population. J. Clin. Periodontol. 40, 977–985. 10.1111/jcpe.12154 [DOI] [PubMed] [Google Scholar]
  58. Thorstensson H., Dahlén G., Hugoson A. (1995). Some Suspected Periodontopathogens and Serum Antibody Response in Adult Long-Duration Insulin-dependent Diabetics. J. Clin. Periodontol. 22, 449–458. 10.1111/j.1600-051x.1995.tb00176.x [DOI] [PubMed] [Google Scholar]
  59. Tsalamandris S., Antonopoulos A. S., Oikonomou E., Papamikroulis G. A., Vogiatzi G., Papaioannou S., et al. (2019). The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives. Eur. Cardiol. 14, 50–59. 10.15420/ecr.2018.33.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. U.S. Food & Drug Administration. (2020). Cigarette Smoking: A Risk Factor for Type 2 Diabetes. Available at: https://www.fda.gov/tobacco-products/health-information/cigarette-smoking-risk-factor-type-2-diabetes [Accessed March 6, 2021].
  61. Vergnes J. N. (2015). Review Finds Periodontal Treatment Has Short Term Benefits for Diabetics. Evid. Based Dent 16, 78–79. 10.1038/sj.ebd.6401114 [DOI] [PubMed] [Google Scholar]
  62. Wang T. F., Jen I. A., Chou C., Lei Y. P. (2014). Effects of Periodontal Therapy on Metabolic Control in Patients with Type 2 Diabetes Mellitus and Periodontal Disease: a Meta-Analysis. Medicine (Baltimore) 93, e292. 10.1097/md.0000000000000292 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wang X., Han X., Guo X., Luo X., Wang D. (2014). The Effect of Periodontal Treatment on Hemoglobin A1c Levels of Diabetic Patients: a Systematic Review and Meta-Analysis. PLoS One 9, e108412. 10.1371/journal.pone.0108412 [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. World Health Organization. (2018). The Top 10 Causes of Death. Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death [Accessed March 6, 2021].
  65. Wu C. Z., Yuan Y. H., Liu H. H., Li S. S., Zhang B. W., Chen W., et al. (2020). Epidemiologic Relationship between Periodontitis and Type 2 Diabetes Mellitus. BMC Oral Health 20, 204. 10.1186/s12903-020-01180-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Yavorska O. O., Burgess S. (2017). Mendelian Randomization: an R Package for Performing Mendelian Randomization Analyses Using Summarized Data. J. Epidemiol. 46, 1734–1739. 10.1093/ije/dyx034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Yuan S., Larsson S. C. (2020). An Atlas on Risk Factors for Type 2 Diabetes: a Wide-Angled Mendelian Randomisation Study. Diabetologia 63, 2359–2371. 10.1007/s00125-020-05253-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Zheng Y., Ley S. H., Hu F. B. (2018). Global Aetiology and Epidemiology of Type 2 Diabetes Mellitus and its Complications. Nat. Rev. Endocrinol. 14, 88–98. 10.1038/nrendo.2017.151 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Click here for additional data file. (11.9KB, XLSX)

Data Availability Statement

Publicly available datasets were analyzed in this study. These data can be found here: United Kingdom Biobank Summary Statistics: http://www.nealelab.is/uk-biobank/; MAGIC https://magicinvestigators.org; DIAMANTE https://magicinvestigators.org; AGEN https://hugeamp.org/downloads.html#T2D; FinnGenn https://www.finngen.fi/fi; and Biobank Japan http://jenger.riken.jp/result.

Articles from Frontiers in Genetics are provided here courtesy of Frontiers Media SA

RESOURCES